Polaris Health Directions has partnered with the MD Anderson Cancer Center at Cooper to conduct an integrated medical-behavioral health pilot project, using the Apple Watch to capture behavioral data that could affect the courses and outcomes of treatment for breast cancer patients.
Polaris provides the following overview of the pilot project:
- Polaris will underwrite the devices (Apple Watch™ Sport 38mm models with pink straps) and development of the app, being responsible for configuration, scientific content design, deployment, monitoring, and support for the wearables platform.
- MD Anderson Cooper will select a group of breast cancer patients in active treatment, provide personnel and support, and will consult on product design and usability within the health network, as well as within patients’ non-institutional settings. Their health professionals will review the data captured and provide patient support based on the analysis of the data.
- The project will undergo review and is subject to approval by the Cooper Institutional Review Board. With the support of the IRB, MD Anderson Cooper and Polaris could then jointly publish project findings, at intervals to be determined.
The project will focus on how patients cope with anxiety and depression during two stages of cancer: immediately after they’ve been diagnosed, and after treatment is completed. Researchers at MD Anderson Cooper expect that using the Apple Watch will help increase engagement and collect data that enables them to refine patient treatment plans.